Advertisement

Amino Acids

, Volume 45, Issue 5, pp 1133–1142 | Cite as

Oral branched-chain amino acid supplements that reduce brain serotonin during exercise in rats also lower brain catecholamines

  • SuJean Choi
  • Briana DiSilvio
  • Madelyn H. Fernstrom
  • John D. FernstromEmail author
Original Article

Abstract

Exercise raises brain serotonin release and is postulated to cause fatigue in athletes; ingestion of branched-chain amino acids (BCAA), by competitively inhibiting tryptophan transport into brain, lowers brain tryptophan uptake and serotonin synthesis and release in rats, and reputedly in humans prevents exercise-induced increases in serotonin and fatigue. This latter effect in humans is disputed. But BCAA also competitively inhibit tyrosine uptake into brain, and thus catecholamine synthesis and release. Since increasing brain catecholamines enhances physical performance, BCAA ingestion could lower catecholamines, reduce performance and thus negate any serotonin-linked benefit. We therefore examined in rats whether BCAA would reduce both brain tryptophan and tyrosine concentrations and serotonin and catecholamine synthesis. Sedentary and exercising rats received BCAA or vehicle orally; tryptophan and tyrosine concentrations and serotonin and catecholamine synthesis rates were measured 1 h later in brain. BCAA reduced brain tryptophan and tyrosine concentrations, and serotonin and catecholamine synthesis. These reductions in tyrosine concentrations and catecholamine synthesis, but not tryptophan or serotonin synthesis, could be prevented by co-administering tyrosine with BCAA. Complete essential amino acid mixtures, used to maintain or build muscle mass, were also studied, and produced different effects on brain tryptophan and tyrosine concentrations and serotonin and catecholamine synthesis. Since pharmacologically increasing brain catecholamine function improves physical performance, the finding that BCAA reduce catecholamine synthesis may explain why this treatment does not enhance physical performance in humans, despite reducing serotonin synthesis. If so, adding tyrosine to BCAA supplements might allow a positive action on performance to emerge.

Keywords

Exercise Tryptophan Tyrosine Serotonin Catecholamines Rat 

Notes

Acknowledgments

These studies were supported by a grant from Ajinomoto North America.

Conflict of interest

John D. Fernstrom is an occasional scientific consultant to the Ajinomoto Company on matters unrelated to the content of this manuscript. The other authors declare that they have no conflict of interest.

References

  1. Bailey SP, Davis JM, Ahlborn EN (1992) Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol Scand 145:75–76PubMedCrossRefGoogle Scholar
  2. Bailey SP, Davis JM, Ahlborn EN (1993) Serotonergic agonists and antagonists affect endurance performance in the rat. Int J Sports Med 14:330–333PubMedCrossRefGoogle Scholar
  3. Blomstrand E, Hassmen P, Ekblom B, Newsholme EA (1991) Administration of branched-chain amino acids during sustained exercise–effects on performance and on plasma concentration of some amino acids. Eur J Appl Physiol 63:83–88CrossRefGoogle Scholar
  4. Bongiovanni R, Yamamoto BK, Jaskiw GE (2001) Improved method for the measurement of large neutral amino acids in biological matrices. J Chromatog B 754:369–376CrossRefGoogle Scholar
  5. Carlsson A, Lindqvist M (1978) Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino acids in rat brain. Naunyn Schmied Arch Pharmacol 303:157–164CrossRefGoogle Scholar
  6. Choi S, DiSilvio B, Fernstrom MH, Fernstrom JD (2009) Meal ingestion, amino acids and brain neurotransmitters: effects of dietary protein source on serotonin and catecholamine synthesis rates. Physiol Behav 98:156–162PubMedCrossRefGoogle Scholar
  7. Davis JM, Alderson NL, Welsh RS (2000) Serotonin and central nervous system fatigue: nutritional considerations. Am J Clin Nutr 72:573S–578SPubMedGoogle Scholar
  8. Fernstrom JD (1983) Role of precursor availability in the control of monoamine biosynthesis in brain. Physiol Rev 63:484–546PubMedGoogle Scholar
  9. Fernstrom JD, Faller DV (1978) Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem 30:1531–1538PubMedCrossRefGoogle Scholar
  10. Fernstrom MH, Fernstrom JD (1987) Protein consumption increases tyrosine concentration and in vivo tyrosine hydroxylation rate in the light-adapted rat retina. Brain Res 401:392–396PubMedCrossRefGoogle Scholar
  11. Fernstrom MH, Fernstrom JD (1995a) Effect of chronic protein ingestion on rat central nervous system tyrosine levels and in vivo tyrosine hydroxylation rate. Brain Res 672:97–103PubMedCrossRefGoogle Scholar
  12. Fernstrom MH, Fernstrom JD (1995b) Acute tyrosine depletion reduces tyrosine hydroxylation rate in rat central nervous system. Life Sci 57:PL97–PL102PubMedCrossRefGoogle Scholar
  13. Fernstrom MH, Fernstrom JD (1995c) Brain tryptophan concentrations and serotonin synthesis remain responsive to food consumption after the ingestion of sequential meals. Am J Clin Nutr 61:312–319PubMedGoogle Scholar
  14. Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173:149–152PubMedCrossRefGoogle Scholar
  15. Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 178:414–416PubMedCrossRefGoogle Scholar
  16. Fernstrom MH, Volk EA, Fernstrom JD (1986) In vivo inhibition of tyrosine uptake into rat retina by large neutral but not acidic amino acids. Am J Physiol 251:E393–E399PubMedGoogle Scholar
  17. Friedman PA, Kappelman AH, Kaufman S (1972) Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem 247:4165–4173PubMedGoogle Scholar
  18. Gartside SE, Cowen PJ, Sharp T (1992) Evidence that the large neutral amino acid l-valine decreases electrically-evoked release of 5-HT in rat hippocampus in vivo. Psychopharmacology 109:251–253PubMedCrossRefGoogle Scholar
  19. Gijsman HJ, Scarna A, Harmer CJ, McTavish SB, Odontiadis J, Cowen PJ, Goodwin GM (2002) A dose-finding study on the effects of branch chain amino acids on surrogate markers of brain dopamine function. Psychopharmacology 160:192–197PubMedCrossRefGoogle Scholar
  20. Hobson RM, Watson P, Maughan RJ (2013) Acute tryptophan depletion does not improve endurance cycling capacity in a warm environment. Amino Acids 44:983–991PubMedCrossRefGoogle Scholar
  21. Hundal HS, Rennie MJ, Watt PW (1989) Characteristics of acidic, basic and neutral amino acid transport in the perfused rat hindlimb. J Physiol Lond 408:93–114PubMedGoogle Scholar
  22. Kaufman S (1974) Properties of the pterin-dependent aromatic amino acid hydroxylases. In: Wolstenholme GEW, FitzSimons DW (eds) Aromatic amino acids in the brain (CIBA foundation symposium 22 [New Series]). Elsevier, Amsterdam, pp 85–115Google Scholar
  23. Lieberman HR (2003) Nutrition, brain function and cognitive performance. Appetite 40:245–254PubMedCrossRefGoogle Scholar
  24. McTavish SFB, Cowen PJ, Sharp T (1999) Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 141:182–188PubMedCrossRefGoogle Scholar
  25. Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF (2006) Central fatigue: the serotonin hypothesis and beyond. Sports Med 36:881–909PubMedCrossRefGoogle Scholar
  26. Moir ATB, Eccleston D (1968) The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles. J Neurochem 15:1093–1108PubMedCrossRefGoogle Scholar
  27. Newsholme EA, Blomstrand E (1996) The plasma level of some amino acids and physical and mental fatigue. Experientia 52:413–415PubMedCrossRefGoogle Scholar
  28. Pardridge WM (1979) The role of blood–brain barrier transport of tryptophan and other neutral amino acids in the regulation of substrate-limited pathways of brain amino acid metabolism. J Neural Transm Suppl 15:43–54PubMedGoogle Scholar
  29. Pardridge WM, Oldendorf WH (1975) Kinetic analysis of blood–brain barrier transport of amino acids. Biochim Biophys Acta 401:128–136PubMedCrossRefGoogle Scholar
  30. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, New YorkGoogle Scholar
  31. Phillips SM (2004) Protein requirements and supplementation in strength sports. Nutrition 20:689–695PubMedCrossRefGoogle Scholar
  32. Roelands B, Hasegawa H, Watson P, Piacentini MF, Buyse L, De Schutter G, Meeusen R (2008a) The effects of acute dopamine reuptake inhibition on performance. Med Sci Sports Exerc 40:879–885PubMedCrossRefGoogle Scholar
  33. Roelands B, Goekint M, Heyman E, Piacentini MF, Watson P, Hasegawa H, Buyse L, Pauwels F, De Schutter G, Meeusen R (2008b) Acute norepinephrine reuptake inhibition decreases performance in normal and high ambient temperature. J Appl Physiol 105:206–212PubMedCrossRefGoogle Scholar
  34. Rouch C, Meile MJ, Orosco M (2003) Extracellular hypothalamic serotonin and plasma amino acids in response to sequential carbohydrate and protein meals. Nutr Neurosci 6:117–124PubMedCrossRefGoogle Scholar
  35. Smriga M, Kameishi M, Tanaka T, Kondoh T, Torii K (2002) Preference for a solution of branched-chain amino acids plus glutamine and arginine correlates with free running activity in rats: involvement of serotonergic-dependent processes of lateral hypothalamus. Nutr Neurosci 5:189–199PubMedCrossRefGoogle Scholar
  36. Struder HK, Hollmann W, Platen P, Donike M, Gotzmann A, Weber K (1998) Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm Metab Res 30:188–194PubMedCrossRefGoogle Scholar
  37. Tarnopolsky M (2004) Protein requirements for endurance athletes. Nutrition 20:662–668PubMedCrossRefGoogle Scholar
  38. Tipton KD, Wolfe RR (2004) Protein and amino acids for athletes. J Sports Sci 22:65–79PubMedCrossRefGoogle Scholar
  39. Tipton KD, Ferrando AA, Phillips SM, Doyle D, Wolfe RR (1999) Postexercise net protein synthesis in human muscle from orally administered amino acids. Am J Physiol 276:E628–E634PubMedGoogle Scholar
  40. Tumilty L, Davison G, Beckmann M, Thatcher R (2011) Oral tyrosine supplementation improves exercise capacity in the heat. Eur J Appl Physiol 111:2941–2950PubMedCrossRefGoogle Scholar
  41. US Department of Agriculture, Agricultural Research Service (2006) USDA national nutrient database for standard reference, Release 19. Nutrient database laboratory home page http://www.ars.usda.gov/nutrientdata. Accessed 15 Nov 2007
  42. Watson P, Hasegawa H, Roelands B, Piacentini MF, Looverie R, Meeusen R (2005) Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol 565:873–883PubMedCrossRefGoogle Scholar
  43. Watson P, Enever S, Page A, Stockwell J, Maughan RJ (2012) Tyrosine supplementation does not influence the capacity to perform prolonged exercise in a warm environment. Int J Sport Nutr Exerc Metab 22:363–373Google Scholar
  44. Wilson WM, Maughan RJ (1992) Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol 77:921–924PubMedGoogle Scholar
  45. Wurtman RJ, Larin F, Mostafapour S, Fernstrom JD (1974) Brain catechol synthesis: control by brain tyrosine concentration. Science 185:183–184PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • SuJean Choi
    • 1
  • Briana DiSilvio
    • 2
  • Madelyn H. Fernstrom
    • 2
  • John D. Fernstrom
    • 2
    • 3
    Email author
  1. 1.Department of Biomedical SciencesMarquette UniversityMilwaukeeUSA
  2. 2.Departments of Psychiatry, Pharmacology and Chemical BiologyUniversity of Pittsburgh School of MedicinePittsburghUSA
  3. 3.UPMC/Western Psychiatric Institute and ClinicPittsburghUSA

Personalised recommendations